Stock & Company Details
Geovax Labs Inc $GOVX
Price:
N/A
N/A
10M
$2.6M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.02
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GOVX technical indicators
Latest Geovax Labs Inc (GOVX) indicator readings as of 2026-10-09.
GOVX's 14-day RSI is 18.4, in oversold territory. At $0.28 it is trading 78.4% below its 200-day moving average of $1.30, and below its 50-day average of $0.52. Price sits near the lower Bollinger Band ($0.26 to $0.43). ADX reads 20.2, sitting between trending and range-bound.
Overview
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Finance Bot
Ask your questions
Start by typing a question below.
